ArticleTherapeutic advances in medical oncology2026
Clinical outcomes and genomic landscape of anti-HER2 antibody-drug conjugates in HER2-positive and HER2-low metastatic breast cancer.
Xiujuan Gui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.